← ANALYST RATINGS · TIPRANKS
Globus Medical (GMED): analyst forecast and price target
Analyst consensus
Moderate Buy9 Buy4 Hold0 Sell
Ratings of 13 analysts in the last 3 months12-month forecast
Based on 13 price targets given in the last 3 months, the average target is $98.75, the highest $117, the lowest $82.00. The average is +28.7% from the last price of $76.71.
Analyst ratings 15
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $90.00 → $93.00+3.3% | Buy | +21.2% | Upgrade | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $87.00 → $89.00+2.3% | Buy | +16.0% | Reiterated | 15.10.26on TipRanks 00:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $88.00 → $90.00+2.3% | Buy | +17.3% | Reiterated | 15.10.26on TipRanks 00:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $86.00 → $88.00+2.3% | Buy | +14.7% | Reiterated | 15.10.26on TipRanks 00:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $83.00 → $85.00+2.4% | Buy | +10.8% | Reiterated | 15.10.26on TipRanks 00:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $88.00 → $90.00+2.3% | Buy | +17.3% | Reiterated | 15.10.26on TipRanks 00:05 | — | |
| Thomas Stephan★★★★★★★★★★#3049 · hits 47% · avg +8.4% | Stifel Nicolaus | $76.43 → $85.00+11.2% | Hold | +10.8% | Reiterated | 07.10.26on TipRanks 07:31 | −3.3%next day −0.1% · 5 days +4.5% | ↗ |
| Shagun Singh Chadha★★★★★★★★★★#9557 · hits 48% · avg −0.4% | RBC Capital | $115 → $85.00−26.1% | Buy | +10.8% | Reiterated | 01.10.26on TipRanks 07:55 | −0.8%next day +0.9% · 5 days −2.8% | ↗ |
| Ryan Zimmerman★★★★★★★★★★#3375 · hits 46% · avg +3.3% | BTIG | — | Hold | — | Reiterated | 18.09.26on TipRanks 06:55 | −0.2%next day −1.3% · 5 days −0.7% | ↗ |
| Caitlin Roberts★★★★★★★★★★#1832 · hits 65% · avg +14.7% | Canaccord Genuity | $115 | Buy | +49.9% | Reiterated | 28.08.26on TipRanks 08:30 | +0.7%next day −1.6% · 5 days −5.8% | ↗ |
| Keith Hinton★★★★★★★★★★#7123 · hits 80% · avg +7.0% | Freedom Capital Markets | $87.00 | Hold | +13.4% | Reiterated | 27.08.26on TipRanks Sep 27 05:10 | −1.3%next day +0.7% · 5 days −5.6% | ↗ |
| Vik Chopra★★★★★★★★★★#6076 · hits 45% · avg +1.9% | BMO Capital | $94.00 | Buy | +22.5% | Reiterated | 27.08.26on TipRanks Aug 28 08:55 | −1.3%next day +0.7% · 5 days −5.6% | ↗ |
| Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% | Bank of America Securities | $106 | Buy | +38.2% | Reiterated | 19.08.26on TipRanks 06:55 | +2.0%next day −2.2% · 5 days −5.5% | ↗ |
| Matthew O'Brien★★★★★★★★★★#12031 · hits 41% · avg −4.5% | Piper Sandler | $100 | Buy | +30.4% | Reiterated | 07.08.26on TipRanks 08:01 | +1.0%next day +4.6% · 5 days +3.9% | ↗ |
| Richard Newitter★★★★★★★★★★#1772 · hits 48% · avg +6.6% | Truist Financial | $100 | Buy | +30.4% | Reiterated | 07.08.26on TipRanks 08:01 | +1.0%next day +4.6% · 5 days +3.9% | ↗ |
| David Saxon★★★★★★★★★★#6662 · hits 38% · avg +0.8% | Needham | $117 | Buy | +52.5% | Reiterated | 07.08.26on TipRanks 07:15 | +1.0%next day +4.6% · 5 days +3.9% | ↗ |
| Larry Biegelsen★★★★★★★★★★#2729 · hits 53% · avg +3.8% | Wells Fargo | $103 → $99.00−3.9% | Buy | +29.1% | Reiterated | 07.08.26on TipRanks 07:06 | +1.0%next day +4.6% · 5 days +3.9% | ↗ |
| Mathew Blackman★★★★★★★★★★#2177 · hits 49% · avg +9.2% | TD Cowen | $115 | Buy | +49.9% | Reiterated | 06.08.26on TipRanks Aug 7 04:00 | +0.8%next day +1.0% · 5 days +4.8% | ↗ |
| Patrick Wood★★★★★★★★★★#10768 · hits 50% · avg −2.1% | UBS | $82.00 | Hold | +6.9% | Initiated | 28.07.26on TipRanks Jul 31 21:11 | +2.7%next day +2.6% · 5 days −3.0% | ↗ |
| Matt Miksic★★★★★★★★★★#2645 · hits 55% · avg +3.9% | Barclays | $123 | Buy | +60.3% | Reiterated | 11.05.26on TipRanks 03:45 | −1.9%next day −0.6% · 5 days +3.0% | ↗ |
| Matthew Taylor★★★★★★★★★★#1367 · hits 55% · avg +7.2% | Jefferies | $105 → $115+9.5% | Buy | +49.9% | Reiterated | 08.01.26on TipRanks 08:55 | +4.5%next day −0.8% · 5 days −1.2% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Globus Medical
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $98.75 at a price of $74.90 (+31.8%); now: $98.75 at $76.71 (+28.7%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 0 | 0 | 0 |
| Buy | 9 | 10 | 12 | 18 | 15 | 13 |
| Hold | 1 | 2 | 5 | 8 | 8 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $1.20 (from $1.13 to $1.26). Last quarter: $1.34.
Sales
Next quarter’s sales estimate — $792M (from $776M to $813M). Last quarter: $790M.
Best top-analyst consensus in the sector · Healthcare
About Globus Medical
- CEO: Keith W. Pfeil
- Employees: 6,000
- 2560 General Armistead Avenue, Audubon, PA, 19403-5214, US
- www.globusmedical.com
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Data from the stock’s TipRanks forecast page, read 53 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗